Discover Tarceva® (erlotinib) Tablets, a treatment for advanced-stage non-small cell lung cancer (NSCLC) and advanced-stage pancreatic cancer. Who is Tarceva for?
Erlotinib hydrochloride (trade name Tarceva) is a drug used to treat non-small cell lung cancer (NSCLC), pancreatic cancer and several other types of cancer.
Easy to read patient leaflet for erlotinib. Includes indications, proper use, special instructions, precautions, and possible side effects.
erlotinib (Tarceva) is a drug prescribed to treat non-small cell lung cancer, metastatic prostate cancer, and pancreatic cancer.
Erlotinib is used to treat non-small cell lung cancer that has spread to nearby tissues or to other parts of the body in patients who have already been ...
Find patient medical information for erlotinib oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.
Learn about the prescription medication Tarceva (Erlotinib), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling.
This page contains brief information about erlotinib hydrochloride and a collection of links to more information about the use of this drug, research results, and ...
Read about the cancer treatment drug erlotinib, otherwise known as Tarceva, including what it is, how it works and possible side effects.
(er-LOE-tye-nib) Trade name: Tarceva ® Tarceva is the trade name for the generic drug name Erlotinib. In some cases, health care professionals may use the trade name ...